Investing.com - Procter&Gamble (NYSE: PG) reported fourth quarter EPS of $1.37, $0.05 better than the analyst estimate of $1.32. Revenue for the quarter came in at $20.6B versus the consensus estimate of $19.97B.
Guidance
Procter&Gamble sees FY 2024 EPS of $6.25-$6.43 versus the analyst consensus of $6.38.
Procter&Gamble's stock price closed at $152.11. It is down -2.73% in the last 3 months and up 9.50% in the last 12 months.
Procter&Gamble saw 6 positive EPS revisions and 2 negative EPS revisions in the last 90 days. See Procter&Gamble's stock price’s past reactions to earnings here.
According to InvestingPro, Procter&Gamble's Financial Health score is "good performance".
Check out Procter&Gamble's recent earnings performance, and Procter&Gamble's financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar